組織名
(NC名) |
PMID |
掲載年
(Year.) |
Title |
Author |
Journal |
| NCC |
41032427 |
2025 |
Near-Infrared Photoimmunotherapy Targeting Esophagogastric Junction Adenocarcinoma With Fully Human Anti-EpCAM Antibody |
Sasabe M, Takashima K, Sakashita S, Koga Y, Anzai T, Yang S, Saijou S, Ishikawa A, Yamaguchi T, et al. |
Cancer Sci. Online ahead of print. |
| NCC |
41032288 |
2025 |
Stratifying lung adenocarcinoma risk with multi-ancestry polygenic risk scores in East Asian never-smokers. |
Blechter B, Wang X, Dai J, Karsonaki C, Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, et al. |
J Natl Cancer Inst. 2025 Oct 1:djaf272. |
| NCC |
41027671 |
2025 |
Dynamic modulation of claudin18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapy. |
Lim SH, Kuwata T, An M, Hong JY, Kim ST, Matsubara Y, Shitara K, Lee J. |
J Immunother Cancer. 13(9):e012683 |
| NCC |
40986990 |
2025 |
Unveiling the molecular and clinical risk landscape of second primary lung cancer in resected non-small cell lung cancer. |
Takemura C, Yoshida T, Yoshida Y, Inaba Higashiyama R, Horinouchi H, Igaki H, Yamamoto N, Yatabe Y, Watanabe SI. |
Lung Cancer 2025; 208: 108750. https://doi.org/10.1016/j.lungcan.2025.108750 |
| NCC |
40985041 |
2025 |
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS 1 metastatic gastric/gastroesophageal junction cancer. |
Zhang F, Nakayama I, Sakamoto N, Okemoto D, Jubashi A, Matsubara Y, Miyashita Y, Sato S, Ushiyama S, et al. |
Ther Adv Med Oncol. 17:17588359251369042 |
| NCC |
40912657 |
2025 |
Translational Analysis of NSD3 Gene Amplification in Lung Squamous Cell Carcinoma: Clinical and Prognostic Insights From Histopathologic Analysis of Patient Samples. |
Takahashi S, Taki T, Nakamura N, Ura A, Kubota S, Miyoshi T, Tane K, Matsumura Y, Samejima J, et al. |
J Thorac Oncol. Online ahead of print. |
| NCC |
40890356 |
2025 |
Myoepithelial carcinoma of the uterine corpus with EWSR1::ZNF444 fusion: a case report. |
Yoshida H, Saito A. |
Virchows Arch. 2025. Epub 2025/09/02. doi: 10.1007/s00428-025-04238-8. PubMed PMID: 40890356. |
| NCC |
40887557 |
2025 |
Progression of Follicular Thyroid Carcinomas to Anaplastic Thyroid Carcinomas: Molecular and Clinicopathologic Characteristics with Comparison to Papillary Thyroid Carcinoma-Derived Anaplastic Thyroid Carcinomas. |
Odate T, Kondo T, Katoh R, Ito K, Ueno T, Yatabe Y, Mori T. |
Endocr Pathol 2025; 36: 30. https://doi.org/10.1007/s12022-025-09875-y |
| NCC |
40876064 |
2025 |
Prediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal data. |
Tateishi A, Horinouchi H, Kouno N, Takeda K, Takasawa K, Mizuno T, Okubo Y, Yoshida Y, Miyake M, et al. |
Lung Cancer 2025; 207: 108727. https://doi.org/10.1016/j.lungcan.2025.108727 |
| NCC |
40865920 |
2025 |
Flat cell variant of lung adenocarcinoma in situ. |
Oka N, Kishikawa S, Kashima J, Watanabe H, Kusumoto M, Asakura K, Watanabe SI, Yatabe Y. |
Mod Pathol. 2025 Aug 25;38(12):100876. |
| NCC |
40849561 |
2025 |
Immunohistochemical evaluation of CREM in CREB-rearranged mesenchymal tumors and their mimics. |
Nishino S, Sugino H, Arai Y, Hama N, Shibata T, Osaki S, Yoshimoto S, Yatabe Y, Mori T, et al. |
Virchows Arch. 2025 Aug 23. |
| NCC |
40842575 |
2025 |
Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr). |
Funasaka C, Naito Y, Kubota H, Ishiguro Y, Fuse N, Wakabayashi M, Sato A, Yuda J, Ishii G, et al. |
Front Oncol. 15:1633324 |
| NCC |
40825170 |
2025 |
Clinical Significance of Extrachromosomal DNA in FGFR2-Amplified Gastric Cancer: Therapeutic Implications From Clinical Experience. |
Aoki Y, Hashimoto T, Takahashi N, Okunaka M, Mishima S, Kotani D, Kawazoe A, Nakamura Y, Nakayama I, et al. |
JCO Precis Oncol. 9:e2500033 |
| NCC |
40796404 |
2025 |
Exacerbation of cancer-associated retinopathy with anti-recoverin antibodies during atezolizumab treatment for extensive-stage small cell lung cancer: A case report. |
Nakamura T, Yoshida T, Kitamoto K, Masuda K, Chen YN, Goto Y. |
Respir Investig. 2025 Sep;63(5):1033-1036. |
| NCC |
40796139 |
2025 |
TP53 gene and pathway alterations in gastric-type adenocarcinoma of the cervix. |
Higuchi D, Yamaguchi M, Fujii E, Kato MK, Hiranuma K, Asami Y, Ono H, Koyama T, Komatsu M, et al. |
JNCI Cancer Spectr. 2025 Sep 1;9(5):pkaf082. |
| NCC |
40760194 |
2025 |
Comparison between a Luminex-based multiplex kit with a sequence-specific oligonucleotide probe and next-generation sequencing for the detection of POLE oncogenic mutations in endometrial cancer. |
Mayumi Kobayashi Kato, Takayuki Kawai, Hideki Okada, Takuya Kondo,Tetsuro Shiraishi, Maiko Yamaguchi, Daiki Higuchi, Masaaki Komatsu, Ryuji Hamamoto, et al. |
Virchows Arch. 2025. Epub 2025/08/05. doi: 10.1007/s00428-025-04204-4. PubMed PMID: 40760194. |
| NCC |
40749150 |
2025 |
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological Factors. |
Jubashi A, Nakayama I, Sakamoto N, Takei S, Matsubara Y, Miyashita Y, Sato S, Ushiyama S, Kobayashi A, et al. |
JCO Precis Oncol. 9:e2400925 |
| NCC |
40731369 |
2025 |
Dynamic nature of hepatic differentiation in lung adenocarcinoma. |
Takemura C, Kishikawa S, Kashima J, Igaki H, Kusumoto M, Ohe Y, Watanabe SI, Yatabe Y. |
Histopathology. 2025 Oct;87(4):565-572.https://doi.org/10.1111/his.15517 |
| NCC |
40716751 |
2025 |
Feasibility of Histological Grading System of Small-sized Pulmonary Adenocarcinoma Based on Frozen Section as a Predictor for Nodal Metastasis. |
Sasahara Y, Fumimoto S, Ohtani-Kim SJ, Tane K, Miyoshi T, Samejima J, Aokage K, Kojima M, Sakashita S, et al. |
Mod Pathol. Online ahead of print. |
| NCC |
40670667 |
2025 |
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy. |
Sakai SA, Oyoshi H, Nakamura M, Taki T, Nomura K, Hojo H, Hirata H, Motegi A, Nakamura Y, et al. |
Br J Cancer. 133(6):795-808 |
| NCC |
40627846 |
2025 |
EML4-ALK-rearrangement constructs a distinctive myeloid-cell-dominant immunosuppressive microenvironment in lung cancer. |
Arai K, Nishito Y, Mizuno H, Motoi N, Hiraoka N, Fuse M, Arai Y, Shibata T, Sonobe Y, et al. |
Cancer Immunol Res 13:1435-1452, 2025. |
| NCC |
40620529 |
2025 |
Favorable response to nivolumab combined with radiotherapy for retroperitoneal leiomyosarcoma. |
Ishihara S, Shiraishi K, Yoshida A, Mori T, Ueno T, Ono H, Ichikawa H, Yagishita S, Kohsaka S, et al. |
Int Cancer Conf J. 2025 May 16;14(3):190-197. |
| NCC |
40523447 |
2025 |
Correlation with CD79B expression and clinicopathological parameters including cell of origin, CD79A and CD19 expression, and CD79B mutation in diffuse large B-cell lymphoma. |
Kaimi Y, Shibata M, Fukuhara S, Takahashi Y, Ochi T, Makita S, Iwaki N, Munakata W, Izutsu K, et al. |
Hum Pathol 2025: 105852. https://doi.org/10.1016/j.humpath.2025.105852 |
| NCC |
40516820 |
2025 |
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma. |
Cho H, Shiraishi K, Sunami K, Momozawa Y, Yoshida T, Matsumoto S, Matsuda K, Saito M, Goto A, et al. |
J Thorac Oncol. 2025 Jun 15:S1556-0864(25)00764-6. |
| NCC |
40507343 |
2025 |
Surgery for T1/2N0 Oropharyngeal Carcinoma Is a Better Treatment Option than Radiotherapy-A Long-Term Follow-Up Study from a Single Japanese High-Volume Cancer Center. |
Rokugo M, Shinozaki T, Ishii R, Ito Y, Sakashita S, Ishii G, Ogawa T, Katori Y, Matsuura K, et al. |
Cancers (Basel). 17(11):1862 |
| NCC |
40487855 |
2025 |
Low density of intratumoral M1-macrophage infiltration may correlate with worse prognosis in low-grade early-stage uterine endometrioid carcinoma. |
Nagamine M, Ogi H, Hirai M, Omatsu I, Moriwaki S, Shibata S, Yasukawa S, Yoriki K, Kojima M, et al. |
Gynecol Oncol Rep. 59:101758 |
| NCC |
40455642 |
2025 |
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study. |
Hashimoto T, Iida N, Nakamura Y, Nonomura N, Morizane C, Iwata H, Okano S, Yamagami W, Yamazaki N, et al. |
Cancer Sci. 116(8):2218-2231 |
| NCC |
40436435 |
2025 |
Merkel Cell Carcinosarcoma: Wnt Pathway Activation Associated With Sarcomatoid Transformation |
Kishikawa S, Tsuruta S, Nakano E, Ogata D, Namikawa K, Yamazaki N, Yatabe Y, Mori T. |
J Cutan Pathol. 2025 May 28. doi: 10.1111/cup.14825. Online ahead of print. |
| NCC |
40424708 |
2025 |
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer. |
Funasaka C, Kogawa T, Sakamoto N, Kusuhara S, Nakao T, Nakajima H, Kondoh C, Harano K, Matsubara N, et al. |
Cancer Treat Res Commun. 44:100941 |
| NCC |
40413654 |
2025 |
Clinical presentation and prognostic factors of eyelid sebaceous carcinoma |
Aihara Y, Ikegami M, Suehara Y, Watanabe T, Yoshimoto S, Mori T, Mano H, Kohsaka S, Suzuki S. |
Jpn J Ophthalmol. 2025 Jul;69(4):595-605. doi: 10.1007/s10384-025-01187-2. Epub 2025 May 25. |
| NCC |
40403695 |
2025 |
Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis. |
Yazaki S, Hori M, Aiba H, Momozawa Y, Yoshida M, Shiino S, Harano K, Yamauchi C, Yamanaka T, et al. |
EBioMedicine. 2025 Jun;116:105758. |
| NCC |
40371227 |
2025 |
Epigenetic disruption of adipogenic gene enhancers in dedifferentiated liposarcomas and its therapeutic value. |
Hattori N, Takamatsu H, Iida N, Asano N, Yamashita S, Oba GM, Kimura K, Yoshida A, Kobayashi E, et al. |
Front Oncol, 15: 1419877, 2025. |
| NCC |
40368772 |
2025 |
A Fatal Case of Immune Checkpoint Inhibitor-Associated Myocarditis with Severe Right Ventricular Failure. |
Imaoka T, Sato K, Sakashita S, Shibutani Y, Suzuki A, Kotani D, Shitara K, Tajiri K. |
Int Heart J. 66(3):511-515 |
| NCC |
40267983 |
2025 |
Geographic and age variations in mutational processes in colorectal cancer. |
Díaz-Gay M, Dos Santos W, Moody S, Kazachkova M, Abbasi A, Steele CD, Vangara R, Senkin S, Wang J, et al. |
Nature. 2025 Jul;643(8070):230-240. |
| NCC |
40253665 |
2025 |
Establishment and characterization of NCC-PS2-C1: a novel cell line of high-grade pleomorphic spindle cell sarcoma, most consistent with myxofibrosarcoma. |
Iwata S,Noguchi R, Oosaki J, Adachi Y, Shiota Y, Osaki S, Nishino S, Yoshida A, Ohtori S, et al. |
Hum Cell. 2025 Apr 20;38(3):93. doi: 10.1007/s13577-025-01217-8. PMID: 40253665. |
| NCC |
40251768 |
2025 |
Upfront liquid biopsy in patients with advanced solid tumors who were not feasible for tissue-based next-generation sequencing. |
Fukuda A, Mizuno T, Yoshida T, Sunami K, Kubo T, Koyama T, Yonemori K, Okusaka T, Kato K, et al. |
Jpn J Clin Oncol 2025; 55: 720-728. https://doi.org/10.1093/jjco/hyaf065 |
| NCC |
40249300 |
2025 |
Novel and Effective Blood-Based miRNA Diagnostic Panel for Gastric Cancer: A Pilot Study in a Japanese Population. |
Murano T, Chung KY, Tang YC, Kano Y, Takeuchi K, Sakamoto N, Kuwata T, Gao Y, Cheong JK, et al. |
Cancer Med. 14(8):e70790 |
| NCC |
40216327 |
2025 |
Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L). |
Hamada A, Soh J, Hata A, Nakamatsu K, Shimokawa M, Yatabe Y, Suzuki J, Tsuboi M, Horinouchi H, et al. |
J Thorac Oncol 2025; 20: 1098-1107. https://doi.org/10.1016/j.jtho.2025.03.051 |
| NCC |
40210835 |
2025 |
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer. |
Onaga R, Enokida T, Sakashita S, Tanaka N, Hoshi Y, Kishida T, Kuboki R, Fujisawa T, Okano S, et al. |
Int J Clin Oncol. 2025 Jun;30(6):1143-1151 |
| NCC |
40210168 |
2025 |
EGR1-BDNF-Linking Crosstalk Between Cancer Cells and Nerves for Perineural Invasion in Salivary Duct Carcinoma: Comparison of Salivary Duct Carcinoma De Novo and Ex Pleomorphic Adenoma. |
Sakyo A, Ryo E, Yoshimoto S, Omura G, Fushimi C, Sakai T, Matsumoto Y, Sakai A, Eguchi K, et al. |
Lab Invest 2025; 105: 104167. https://doi.org/10.1016/j.labinv.2025.104167 |
| NCC |
40178664 |
2025 |
Establishment and characterization of novel cancer cachexia-inducing cell line, Aku60GC, of scirrhous gastric cancer. |
Noguchi R, Yanagihara K, Iino Y, Komatsu T, Kubo T, Ono T, Osaki J, Adachi Y, Iwata S, et al. |
Human cell. 2025 Apr 3;38(3):82. doi: 10.1007/s13577-025-01208-9. |
| NCC |
40169461 |
2025 |
Establishment and characterization of NCC-OS2-C1: a novel patient-derived cell line of osteosarcoma. |
Iwata S, Noguchi R, Oosaki J, Adachi Y, Shiota Y, Ogura K, Nishino S, Yoshida A, Ohtori S, et al. |
Hum Cell. 2025 Apr 2;38(3):81. doi: 10.1007/s13577-025-01198-8. PMID: 40169461. |
| NCC |
40158055 |
2025 |
Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma. |
Zachary A Cooper; Ying Wang; Philip L Martin; Kosho Murayama; Rakesh Kumar; Ken Kato; Shun Yamamoto; Shigeki Sekine. |
Discover oncology |
| NCC |
40139500 |
2025 |
Nosologic Reappraisal of the Recently Proposed Calcified Chondroid Mesenchymal Neoplasm Concept in a Series of 20 Cases. |
Shogo Nishino; Taisuke Mori; Hajime Umezu; Kohtaro Eguchi; Toshihide Hirai; Ryouji Yamada; Shinsuke Ohshima; Yasushi Yatabe; Seiichi Yoshimoto; Akira Kawai; Toru Motoi; Akihiko Yoshida. |
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc |
| NCC |
40126770 |
2025 |
Establishment and characterization of NCC-dCS2-C1: a novel patient-derived cell line of dedifferentiated chondrosarcoma. |
Shuhei Iwata; Takuya Ono; Rei Noguchi; Julia Osaki; Yuki Adachi; Yomogi Shiota; Suguru Fukushima; Shogo Nishino; Akihiko Yoshida; Seiji Ohtori; Akira Kawai; Tadashi Kondo. |
Human cell |
| NCC |
40115982 |
2025 |
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study. |
Shogo Takei; Daisuke Kotani; George Laliotis; Kazuma Sato; Naoto Fujiwara; Akihito Kawazoe; Tadayoshi Hashimoto; Saori Mishima; Izuma Nakayama; Yoshiaki Nakamura; Hideaki Bando; Yasutoshi Kuboki; Shingo Sakashita; Erik Spickard; Giby V George; Punashi Dutta; Shruti Sharma; Meenakshi Malhotra; Himanshu Sethi; Adham Jurdi; Minetta C Liu; Takayuki Yoshino; Kohei Shitara; Takashi Kojima; Takeo Fujita. |
Annals of surgery |
| NCC |
40091523 |
2025 |
Successful Multidisciplinary Treatment of Tracheal Lymphoepithelial Carcinoma in an Adolescent Patient. |
Ayumu Arakawa; Minako Sugiyama; Eriko Uchida; Bunpei Miyazaki; Kayoko Tao; Kiyotaka Isobe; Tomoya Kaneda; Jumpei Kashima; Yasushi Yatabe; Hajime Tsuruoka; Chitose Ogawa. |
Pediatric blood & cancer |
| NCC |
40088580 |
2025 |
Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma. |
Masahiro Torasawa; Tatsuya Yoshida; Kouya Shiraishi; Shigehiro Yagishita; Hanako Ono; Yuji Uehara; Jun Miyakoshi; Akiko Tateishi; Yukiko Shimoda Igawa; Ryoko Inaba Higashiyama; Akifumi Mochizuki; Ken Masuda; Yuji Matsumoto; Yuki Shinno; Yusuke Okuma; Yasushi Goto; Hidehito Horinouchi; Ryuji Hamamoto; Noboru Yamamoto; Shun-Ichi Watanabe; Yasushi Yatabe; Kazuhisa Takahashi; Takashi Kohno; Yuichiro Ohe. |
Lung cancer (Amsterdam, Netherlands) |
| NCC |
40076777 |
2025 |
Expression Profiles of Five Common Cancer Membrane Protein Antigens Collected for the Development of Cocktail CAR-T Cell Therapies Applicable to Most Solid Cancer Patients. |
Tetsuya Nakatsura; Kazumasa Takenouchi; Jun Kataoka; Yusuke Ito; Sae Kikuchi; Hiroki Kinoshita; Kazunobu Ohnuki; Toshihiro Suzuki; Nobuo Tsukamoto. |
International journal of molecular sciences |
| NCC |
40029791 |
2025 |
Feasibility of Intratumoral Administration With EPHB4-CAR-T Cells for the Treatment of Oral Squamous Cell Carcinoma. |
Yusuke Ito; Toshihiro Suzuki; Manami Shimomura; Kazumasa Takenouchi; Kazunobu Ohnuki; Kayoko Shoda; Yuka Kenmochi; Shigeki Yagyu; Kazuto Matsuura; Ryuichi Hayashi; Tetsuya Nakatsura. |
Cancer science |
| NCC |
40007550 |
2025 |
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma. |
Yuji Uehara; Hiroki Izumi; Tetsuro Taki; Tetsuya Sakai; Hibiki Udagawa; Eri Sugiyama; Shigeki Umemura; Yoshitaka Zenke; Shingo Matsumoto; Kiyotaka Yoh; Shoko Kubota; Keiju Aokage; Naoya Sakamoto; Shingo Sakashita; Motohiro Kojima; Michiko Nagamine; Yukio Hosomi; Masahiro Tsuboi; Koichi Goto; Genichiro Ishii. |
JTO clinical and research reports |
| NCC |
39980125 |
2025 |
PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer. |
Kenji Harada; Naoya Sakamoto; Takumi Kitaoka; Yuka Nakamura; Ryotaro Kondo; Ryo Morisue; Hiroko Hashimoto; Yusuke Yamamoto; Shoichi Ukai; Ryota Maruyama; Shingo Sakashita; Motohiro Kojima; Kazuaki Tanabe; Hideki Ohdan; Kohei Shitara; Takahiro Kinoshita; Genichiro Ishii; Wataru Yasui; Atsushi Ochiai; Shumpei Ishikawa. |
The Journal of pathology |
| NCC |
39948701 |
2025 |
Single-Nucleus RNA Sequencing and Spatial Transcriptomics for Squamous Cell Carcinoma Arising From Ovarian Mature Teratoma. |
Kosuke Yoshida; Akira Yokoi; Hironori Suzuki; Satoshi Tamauchi; Masami Kitagawa; Eri Inami; Jun Nakayama; Yutaro Mori; Koji Okamoto; Yutaka Suzuki; Hiroshi Yoshida; Tomoyasu Kato; Hiroaki Kajiyama; Yusuke Yamamoto. |
Cancer science |
| NCC |
39938154 |
2025 |
Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers. |
Hiroki Kinoshita; Kazumasa Takenouchi; Nobuo Tsukamoto; Kazunobu Ohnuki; Toshihiro Suzuki; Tetsuya Nakatsura. |
Neoplasia (New York, N.Y.) |
| NCC |
39934302 |
2025 |
Establishment of a machine learning model for predicting splenic hilar lymph node metastasis. |
Kenichi Ishizu; Satoshi Takahashi; Nobuji Kouno; Ken Takasawa; Katsuji Takeda; Kota Matsui; Masashi Nishino; Tsutomu Hayashi; Yukinori Yamagata; Shigeyuki Matsui; Takaki Yoshikawa; Ryuji Hamamoto. |
NPJ digital medicine |
| NCC |
39930910 |
2025 |
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer. |
Rui Kitadai; Shu Yazaki; Aya Kuchiba; Takashi Yamanaka; Sho Shiino; Chisako Yamauchi; Kenichi Harano; Motonobu Saito; Yosuke Hirotsu; Hisaki Aiba; Teruhiko Yoshida; Ryuji Hamamoto; Chikako Shimizu; Akihiko Shimomura; Yuki Kojima; Tatsunori Shimoi; Yukihide Momozawa; Kazuki Sudo; Masayuki Yoshida; Kuniko Sunami; Megumi Hori; Kota Katanoda; Yoko Shimada; Yuji Yamashita; Takahiro Kogawa; Takeshi Murata; Saori Fujiwara; Yohei Miyagi; Hiroshi Nakagomi; Kazunoshin Tachibana; Masao Omata; Tohru Ohtake; Akihiko Suto; Tatsuya Onishi; Yoichi Naito; Toshinari Yamashita; Kan Yonemori; Takashi Kohno; Kouya Shiraishi. |
Cancer science |
| NCC |
39904835 |
2025 |
Establishment and characterization of NCC-SFT1-C1: a novel patient-derived cell line of solitary fibrous tumor. |
Shuhei Iwata; Rei Noguchi; Julia Oosaki; Yuki Adachi; Yomogi Shiota; Eisuke Kobayashi; Toshiyuki Takemori; Shogo Nishino; Akihiko Yoshida; Seiji Ohtori; Akira Kawai; Tadashi Kondo. |
Human cell |
| NCC |
39868745 |
2025 |
TP53 Mutations and PD-L1 Amplification in Vulvar Adenocarcinoma of the Intestinal Type: Insights From Whole Exome Sequencing of 2 Cases. |
Erisa Fujii; Mayumi Kobayashi Kato; Hanako Ono; Maiko Yamaguchi; Daiki Higuchi; Takafumi Koyama; Masaaki Komatsu; Ryuji Hamamoto; Mitsuya Ishikawa; Tomoyasu Kato; Takashi Kohno; Kouya Shiraishi; Hiroshi Yoshida. |
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists |
| NCC |
39815310 |
2025 |
TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors. |
Yuka Takahashi; Akihiko Yoshida; Seiichi Yoshimoto; Shigenobu Suzuki; Satsuki Kishikawa; Ayaka Mitsui; Eijitsu Ryo; Yuki Kojima; Kan Yonemori; Yasushi Yatabe; Taisuke Mori. |
Diagnostic pathology |
| NCC |
39814862 |
2025 |
Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLC. |
Masayuki Shirasawa; Tatsuya Yoshida; Takaji Matsutani; Yuki Takeyasu; Naoko Goto; Shigehiro Yagishita; Shigehisa Kitano; Hiroaki Kuroda; Toyoaki Hida; Takayasu Kurata; Yuichiro Ohe. |
NPJ precision oncology |
| NCC |
39809728 |
2025 |
Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical Outcomes. |
Ken Masuda; Tatsuya Yoshida; Noriko Motoi; Yuki Shinno; Yuji Matsumoto; Yusuke Okuma; Yasushi Goto; Hidehito Horinouchi; Noboru Yamamoto; Shun-Ichi Watanabe; Tomoaki Hoshino; Yasushi Yatabe; Yuichiro Ohe. |
Thoracic cancer |
| NCC |
39788962 |
2025 |
Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data. |
Naoko Iida; Ai Okada; Yoshihisa Kobayashi; Kenichi Chiba; Yasushi Yatabe; Yuichi Shiraishi. |
Nature communications |
| NCC |
39754977 |
2025 |
Exploring novel therapeutic targets in small bowel adenocarcinoma: insights from claudin 18.2, nectin-4, and HER3 expression analysis. |
H Fujii; H Shoji; H Hirano; T Hirose; N Okita; A Takashima; K Kato. |
ESMO open |
| NCC |
39742833 |
2025 |
Cell of origin and expression profiles of pseudomyxoma peritonei derived from the appendix. |
Rei Noguchi; Kiyoshi Yamaguchi; Hideaki Yano; Yoshimasa Gohda; Tomomichi Kiyomatsu; Yasunori Ota; Toru Igari; Norihiko Takahashi; Tomoyuki Ohsugi; Kiyoko Takane; Tsuneo Ikenoue; Atsushi Niida; Eigo Shimizu; Rui Yamaguchi; Satoru Miyano; Seiya Imoto; Yoichi Furukawa. |
Pathology, research and practice |
| NCC |
39666379 |
2025 |
Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration. |
Shunsuke A Sakai; Koichi Saeki; SungGi Chi; Yamato Hamaya; Junyan Du; Masaki Nakamura; Hidehiro Hojo; Takashi Kojima; Yoshiaki Nakamura; Hideaki Bando; Motohiro Kojima; Ayako Suzuki; Yutaka Suzuki; Tetsuo Akimoto; Katsuya Tsuchihara; Hiroshi Haeno; Riu Yamashita; Shun-Ichiro Kageyama. |
Cancer immunology research |
| NCC |
39652104 |
2025 |
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma. |
Ryoichi Miura; Atsushi Ono; Hikaru Nakahara; Yuki Shirane; Kenji Yamaoka; Yasutoshi Fujii; Shinsuke Uchikawa; Hatsue Fujino; Eisuke Murakami; Tomokazu Kawaoka; Daiki Miki; Masataka Tsuge; Takeshi Kishi; Waka Ohishi; Naoya Sakamoto; Koji Arihiro; Clair Nelson Hayes; Shiro Oka. |
Journal of gastroenterology |
| NCC |
39645554 |
2025 |
Survival Impacts of Mitochondrial Status in Esophageal Squamous Cell Carcinoma Patients. |
Kotaro Sugawara; Shingo Sakashita; Takashi Fukuda; Chiaki Murakami; Daiji Oka; Gulanbar Amori; Kumiko Ishibashi; Yasuhito Kobayashi; Hiroaki Kanda; Noriko Motoi. |
Annals of surgical oncology |
| NCC |
39617100 |
2025 |
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland Neoplasms. |
Airi Sakyo; Eijitsu Ryo; Shogo Nishino; Kenya Kobayashi; Seiichi Yoshimoto; Go Omura; Chihiro Fushimi; Toshihiko Sakai; Azusa Sakai; Kohtaro Eguchi; Hideaki Takahashi; Kazuki Yokoyama; Yoshitaka Honma; Akiko Mori; Hiroko Kato; Toshiyuki Hatano; Akihiko Yoshida; Fumihiko Matsumoto; Yasushi Yatabe; Taisuke Mori. |
Laboratory investigation; a journal of technical methods and pathology |
| NCC |
39592291 |
2025 |
Radiologists Versus AI-Based Software: Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma From CT Under Various Image Display Conditions. |
Junya Sato; Masahiro Yanagawa; Daiki Nishigaki; Akinori Hata; Yukinori Sakao; Noriaki Sakakura; Yasushi Yatabe; Yasushi Shintani; Shoji Kido; Noriyuki Tomiyama. |
Clinical lung cancer |
| NCC |
39591761 |
2025 |
Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma. |
Tetsuya Sekita; Naofumi Asano; Takashi Kubo; Hirohiko Totsuka; Sachiyo Mitani; Naoko Hattori; Akihiko Yoshida; Eisuke Kobayashi; Motokiyo Komiyama; Toshikazu Ushijima; Robert Nakayama; Masaya Nakamura; Akira Kawai; Hitoshi Ichikawa. |
Neoplasia (New York, N.Y.) |
| NCC |
39581378 |
2025 |
Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report. |
Batel Blechter; Chao Agnes Hsiung; Xiaoyu Wang; Haoyu Zhang; Wei Jie Seow; Jianxin Shi; Nilanjan Chatterjee; Hee Nam Kim; Maria Pik Wong; Yun-Chul Hong; Jason Y Y Wong; Juncheng Dai; H Dean Hosgood; Zhaoming Wang; I-Shou Chang; Jiyeon Choi; Jiucun Wang; Minsun Song; Wei Hu; Wei Zheng; Jin Hee Kim; Baosen Zhou; Demetrius Albanes; Min-Ho Shin; Lap Ping Chung; She-Juan An; Hong Zheng; Yasushi Yatabe; Xu-Chao Zhang; Young Tae Kim; Xiao-Ou Shu; Young-Chul Kim; Roel C H Vermeulen; Bryan A Bassig; Jiang Chang; James Chung Man Ho; Bu-Tian Ji; Michiaki Kubo; Yataro Daigo; Yukihide Momozawa; Yoichiro Kamatani; Takayuki Honda; Hideo Kunitoh; Shun-Ichi Watanabe; Yohei Miyagi; Haruhiko Nakayama; Shingo Matsumoto; Masahiro Tsuboi; Koichi Goto; Zhihua Yin; Atsushi Takahashi; Akiteru Goto; Yoshihiro Minamiya; Kimihiro Shimizu; Kazumi Tanaka; Tangchun Wu; Fusheng Wei; Jian Su; Yeul Hong Kim; In-Jae Oh; Victor Ho Fun Lee; Wu-Chou Su; Yuh-Min Chen; Gee-Chen Chang; Kuan-Yu Chen; Ming-Shyan Huang; Hsien-Chih Lin; Adeline Seow; Jae Yong Park; Sun-Seog Kweon; Chien-Jen Chen; Yu-Tang Gao; Chen Wu; Biyun Qian; Daru Lu; Jianjun Liu; Hyo-Sung Jeon; Chin-Fu Hsiao; Jae Sook Sung; Ying-Huang Tsai; Yoo Jin Jung; Huan Guo; Zhibin Hu; Tzu-Yu Chen; Laurie Burdett; Meredith Yeager; Amy Hutchinson; Sonja I Berndt; Wei Wu; Junwen Wang; Jin Eun Choi; Kyong Hwa Park; Sook Whan Sung; Li Liu; Chang Hyun Kang; Chung-Hsing Chen; Jun Xu; Peng Guan; Wen Tan; Chih-Liang Wang; Alan Dart Loon Sihoe; Ying Chen; Yi Young Choi; Jun Suk Kim; Ho-Il Yoon; Qiuyin Cai; In Kyu Park; Ping Xu; Qincheng He; Chih-Yi Chen; Junjie Wu; Wei-Yen Lim; Kun-Chieh Chen; John K C Chan; Jihua Li; Hongyan Chen; Chong-Jen Yu; Li Jin; Joseph F Fraumeni; Jie Liu; Maria Teresa Landi; Taiki Yamaji; Yang Yang; Belynda Hicks; Kathleen Wyatt; Shengchao A Li; Hongxia Ma; Bao Song; Zhehai Wang; Sensen Cheng; Xuelian Li; Yangwu Ren; Motoki Iwasaki; Junjie Zhu; Gening Jiang; Ke Fei; Guoping Wu; Li-Hsin Chien; Fang-Yu Tsai; Jinming Yu; Victoria L Stevens; Pan-Chyr Yang; Dongxin Lin; Kexin Chen; Yi-Long Wu; Keitaro Matsuo; Nathaniel Rothman; Kouya Shiraishi; Hongbing Shen; Stephen J Chanock; Takashi Kohno; Qing Lan. |
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
| NCC |
39572499 |
2025 |
Impact of Lymphatic and Venous Invasion Patterns on Postoperative Prognosis and Distant Metastasis in Esophageal Squamous Cell Carcinoma After Preoperative Chemotherapy. |
Daisuke Kajiyama; Naoto Fujiwara; Takashi Shigeno; Kazuma Sato; Masayuki Yamaguchi; Shingo Sakashita; Hiroyuki Daiko; Takeo Fujita. |
Annals of surgical oncology |
| NCC |
39572460 |
2025 |
The landscape of 142 Epstein-Barr viral whole genomes in gastric cancer. |
Yuki Kojima; Motoharu Hamada; Azumi Naruse; Kimitoshi Goto; Htet Thiri Khine; Haruto Arai; Yuta Akutsu; Akira Satou; Masato Nakaguro; Seiichi Kato; Yasuhiro Kodera; Yasushi Yatabe; Yuka Torii; Jun-Ichi Kawada; Takayuki Murata; Hiroshi Kimura; Shuji Takiguchi; Hiroshi Inagaki; Hiromi Kataoka; Yusuke Okuno. |
Journal of gastroenterology |
| NCC |
39555736 |
2025 |
NETosis in pulmonary pleomorphic carcinoma. |
Hajime Oi; Tetsuro Taki; Takashi Kuroe; Naoya Sakamoto; Shingo Sakashita; Motohiro Kojima; Eri Sugiyama; Shigeki Umemura; Tetsuya Sakai; Hiroki Izumi; Yoshitaka Zenke; Shingo Matsumoto; Kiyotaka Yoh; Makoto Ishii; Masahiro Tsuboi; Koichi Goto; Genichiro Ishii. |
Cancer science |
| NCC |
39487862 |
2025 |
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer. |
Amane Jubashi; Izuma Nakayama; Shigehiro Koganemaru; Naoya Sakamoto; Shioto Oda; Yuki Matsubara; Yu Miyashita; Seiya Sato; Shinpei Ushiyama; Akinori Kobayashi; Ukyo Okazaki; Dai Okemoto; Kazumasa Yamamoto; Saori Mishima; Daisuke Kotani; Akihito Kawazoe; Tadayoshi Hashimoto; Yoshiaki Nakamura; Yasutoshi Kuboki; Hideaki Bando; Takashi Kojima; Takayuki Yoshino; Hisamitsu Miyaaki; Kazuhiko Nakao; Kohei Shitara. |
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association |
| NCC |
39395663 |
2025 |
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib. |
Shigeki Umemura; Hibiki Udagawa; Takaya Ikeda; Haruyasu Murakami; Haruko Daga; Ryo Toyozawa; Toshiyuki Kozuki; Jun Sakakibara-Konishi; Yuichiro Ohe; Masahiro Morise; Terufumi Kato; Masato Shingyoji; Satoshi Hara; Naoki Furuya; Shuhei Teranishi; Saori Takata; Shingo Miyamoto; Ichiro Nakachi; Masashi Wakabayashi; Shogo Nomura; Akihiro Sato; Genichiro Ishii; Katsuya Tsuchihara; Eri Sugiyama; Keisuke Kirita; Tetsuya Sakai; Yuji Shibata; Hiroki Izumi; Kaname Nosaki; Yoshitaka Zenke; Shingo Matsumoto; Kiyotaka Yoh; Seiji Niho; Koichi Goto. |
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
| NCC |
38991945 |
2025 |
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma. |
Mizoguchi C, Nishikawa T, Yoshida H, Yasuda M, Kato T, Hasegawa K, Yonemori K. |
J Gynecol Oncol. 2025 Jan;36(1):e14. doi: 10.3802/jgo.2025.36.e14. Epub 2024 Jul 2. |
| NCC |
38914017 |
2025 |
Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer. |
Yazaki S, Chiba Y, Kojima Y, Yoshida H, Takamizawa S, Kitadai R, Saito A, Kita S, Yamamoto K, et al. |
Int J Gynecol Pathol. 2025 Mar 1;44(2):104-111. doi: 10.1097/PGP.0000000000001051. Epub 2024 Jun 12. |
| NCC |
39725152 |
2024 |
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer. |
Yamamoto G, Tanaka K, Kamata R, Saito H, Yamamori-Morita T, Nakao T, Liu J, Mori S, Yagishita S, et al. |
Cancer Lett. 2024 Dec 24:611:217414. doi: 10.1016/j.canlet.2024.217414. Online ahead of print. |
| NCC |
39654555 |
2024 |
Clinicopathological and molecular features of claudin-18 isoform 2 expression in patients with colorectal cancer: a single-center retrospective study. |
Takamizawa S, Hirano H, Takashima A, Shoji H, Hirose T, Okita N, Shiraishi K, Sekine S, Takamizawa Y, et al. |
Ther Adv Med Oncol. 2024 Dec 8:16:17588359241286774. doi: 10.1177/17588359241286774. eCollection 2024. |
| NCC |
39651731 |
2024 |
Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic Chemotherapy. |
Satake T, Morizane C, Okada M, Nishioka M, Hiraoka N, Nara S, Kakegawa T, Kobayashi M, Koyama K, et al. |
Cancer Med. 2024 Dec;13(23):e70474. doi: 10.1002/cam4.70474. |
| NCC |
39645627 |
2024 |
Establishment and characterization of a novel patient-derived cell line from conventional central grade 3 chondrosarcoma, NCC-CS1-C1. |
Noguchi R, Ono T, Osaki J, Adachi Y, Iwata S, Shiota Y, Yanagihara K, Nishino S, Funada T, et al. |
Hum Cell. 2024 Dec 8;38(1):28. doi: 10.1007/s13577-024-01152-0. |
| NCC |
39639005 |
2024 |
Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development. |
Takano Y, Suzuki J, Nomura K, Fujii G, Zenkoh J, Kawai H, Kuze Y, Kashima Y, Nagasawa S, et al. |
Nat Commun. 2024 Dec 6;15(1):10637. doi: 10.1038/s41467-024-54671-7. |
| NCC |
39560855 |
2024 |
An Institutional Experience of Core Needle Biopsy with Cooperative Implementation by Pathologists and Head and Neck Oncologists in Salivary Gland Carcinoma. |
Kobayashi K, Yoshimoto S, Omura G, Matsumoto Y, Sakai A, Eguchi K, Sakai T, Honma Y, Matsumoto F, et al. |
Head Neck Pathol. 2024 Nov 19;18(1):122. doi: 10.1007/s12105-024-01725-3. |
| NCC |
39453771 |
2024 |
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY). |
Aokage K, Koyama S, Kumagai S, Nomura K, Shimada Y, Yoh K, Wakabayashi M, Fukutani M, Furuya H, et al. |
Clin Cancer Res. 2024 Dec 16;30(24):5584-5592. doi: 10.1158/1078-0432.CCR-24-1561. |
| NCC |
39385713 |
2024 |
Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer |
Miwa M, Kitagawa M, Asami Y, Kobayashi-Kato M, Watanabe T, Ogasawara A, Hiranuma K, Kato H, Saito M, et al. |
Cancer Sci. 2024 Dec;115(12):3952-3962. doi: 10.1111/cas.16367. Epub 2024 Oct 10. |
| NCC |
39373493 |
2024 |
Tumor thickness is associated with metastasis in patients with submucosal invasive adenocarcinoma of the esophagogastric junction. |
Minakata N, Kadota T, Sakashita S, Inaba A, Sunakawa H, Takashima K, Nakajo K, Murano T, Shinmura K, et al. |
Dis Esophagus. 2024 Oct 7:doae083. doi: 10.1093/dote/doae083. Online ahead of print. |
| NCC |
39351646 |
2024 |
Leveraging non-coding regions to guarantee the accuracy of small-sized panel-based tumor mutational burden estimates |
Nishino T, Yumura M, Sunami K, Kubo T, Ichikawa H, Yasuda T, Furukawa E, Nagai M, Yatabe Y, et al. |
Cancer Sci. 2024 Dec;115(12):4045-4053. doi: 10.1111/cas.16342. Epub 2024 Oct 1. |
| NCC |
39338408 |
2024 |
Real-Time Fluorescence Monitoring System for Optimal Light Dosage in Cancer Photoimmunotherapy |
Tanaka H, Koga Y, Sugahara M, Fuchigami H, Ishikawa A, Yamaguchi T, Banba A, Shinozaki T, Matsuura K, et al. |
Pharmaceuticals (Basel). 2024 Sep 22;17(9):1246. doi: 10.3390/ph17091246. |
| NCC |
39327855 |
2024 |
Inflammatory spindle cell PEComa of thelung with YAP1::TFE3 fusion: a report of two cases and a potential relationshipwith clear cell stromal tumour. |
Kojima N, Nishino S, Sasahara Y, Taki T, Imada H, Miyoshi T, Watanabe SI,Ishii G, Yatabe Y, et al. |
Histopathology. 2024 Sep 26. doi:10.1111/his.15328. Epub ahead of print. PMID: 39327855. |
| NCC |
39307824 |
2024 |
Association between pathological T1 colorectal cancer with lymphoid follicular replacement and risk of lymph node metastasis. |
Inaba A, Ikematsu H, Kojima M, Sakamoto N, Wakabayashi M, Sunakawa H, Nakajo K, Murano T, Kadota T, et al. |
J Gastroenterol Hepatol. 2024 Sep 22. doi: 10.1111/jgh.16745. Online ahead of print. |
| NCC |
39303401 |
2024 |
Association between lorlatinib blood concentration and adverse events and clinical impact of dose modification. |
Shimoda Igawa Y, Yoshida T, Makihara R, Torasawa M, Tateishi A, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, et al. |
Lung Cancer. 2024 Sep 12;196:107954. |
| NCC |
39271966 |
2024 |
Correction: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway |
Ikeuchi H, Matsuno Y, Kusumoto-Matsuo R, Kojima S, Ueno T, Ikegami M, Kitada R, Sumiyoshi-Okuma H, Kojima Y, et al. |
Oncogene. 2024 Oct;43(41):3079. doi: 10.1038/s41388-024-03159-1. |
| NCC |
39267678 |
2024 |
Prognostic significance of the FSTL1-DIP2A axis in early-stage tongue cancer. |
Chie Kudo-Saito, Satoko Matsumura, Taisuke Mori, Yoshitaka Honma, Seiichi Yoshimoto. |
American Journal of Cancer Research 14:3816-3825, 2024. |
| NCC |
39242142 |
2024 |
A Response to the Letter to the Editor: Safety Implications of Switching Pembrolizumab Dosage From 200 mg Every 3 Weeks to 400 mg Every 6 Weeks in Patients With Advanced NSCLC |
Higashiyama RI, Yoshida T. |
J Thorac Oncol. 2024 Sep;19(9):e33-e34. doi: 10.1016/j.jtho.2024.06.017. |
| NCC |
39226222 |
2024 |
A novel histopathological feature of spatial tumor-stroma distribution predicts lung squamous cell carcinoma prognosis. |
Taki T, Koike Y, Adachi M, Sakashita S, Sakamoto N, Kojima M, Aokage K, Ishikawa S, Tsuboi M, et al. |
Cancer Sci. 2024 Sep 3. doi: 10.1111/cas.16244. Online ahead of print. |
| NCC |
39225725 |
2024 |
Quantification of Gremlin 1 throughout the tumor stroma using whole slide imaging and its clinicopathological significance in gastric cancer. |
Kitaoka T, Harada K, Sakashita S, Kojima M, Taki T, Kuwata T, Kinoshita T, Futakuchi M, Ishii G, et al. |
Virchows Arch. 2024 Sep 3. doi: 10.1007/s00428-024-03903-8. Online ahead of print. |
| NCC |
39218851 |
2024 |
Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets |
Asada K, Kaneko S, Takasawa K, Shiraishi K, Shinkai N, Shimada Y, Takahashi S, Machino H, Kobayashi K, et al. |
Mol Cancer. 2024 Sep 2;23(1):182. doi: 10.1186/s12943-024-02093-w. |
| NCC |
39199592 |
2024 |
Utility of Transpapillary Biopsy and Endoscopic Ultrasound-GuidedTissue Acquisition for Comprehensive Genome Profiling of Unresectable BiliaryTract Cancer. |
Fukuda S, Hijioka S, Nagashio Y, Yamashige D, Agarie D, Hagiwara Y, OkamotoK, Yagi S, Komori Y, et al. |
Cancers (Basel). 2024 Aug 10;16(16):2819. doi:10.3390/cancers16162819. PMID: 39199592; PMCID: PMC11353131. |
| NCC |
39196622 |
2024 |
Oncofetal IGF2BP3-mediated control of microRNA structural diversity in the malignancy of early-stage lung adenocarcinoma |
Fujiwara Y, Takahashi RU, Saito M, Umakoshi M, Shimada Y, Koyama K, Yatabe Y, Watanabe SI, Koyota S, et al. |
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2407016121. doi: 10.1073/pnas.2407016121. Epub 2024 Aug 28. |
